{"id":"NCT00281697","sponsor":"Genentech, Inc.","briefTitle":"A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)","officialTitle":"A Phase III, Multicenter, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy Regimens in Subjects With Previously Treated Metastatic Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2009-03","completion":"2012-09","firstPosted":"2006-01-25","resultsPosted":"2012-09-24","lastUpdate":"2013-07-26"},"enrollment":684,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Breast Cancer"],"interventions":[{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Standard chemotherapy","otherNames":[]}],"arms":[{"label":"Standard chemotherapy + bevacizumab","type":"EXPERIMENTAL"},{"label":"Standard chemotherapy + placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This phase III, multicenter, randomized, placebo-controlled, blinded trial is designed to evaluate the efficacy and safety of bevacizumab when combined with standard chemotherapy compared with chemotherapy alone in subjects with previously treated metastatic breast cancer.","primaryOutcome":{"measure":"Progression-free Survival","timeFrame":"Baseline to data cut-off for analysis of the primary Outcome Measure (up to 3 years, 2 months)","effectByArm":[{"arm":"Standard Chemotherapy + Bevacizumab","deltaMin":7.2,"sd":null},{"arm":"Standard Chemotherapy + Placebo","deltaMin":5.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":24},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":112,"n":458},"commonTop":["Neutropenia","Hypertension","Peripheral sensory neuropathy"]}}